أرباح التشغيل تغيير تاريخ
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Ardelyx USD 5.1M 431K 2025-12
aTyr Pharma USD 24.47M 51.21M 2025-12
Biogen USD 514.3M 128.8M 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Cipla INR 6.14B 3.63B 2026-03
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD 56.04M 63.93M 2025-12
CSL USD 2.64B 1.97B 2025-12
Curis USD -7.88M 4.63M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Grifols EUR 320.55M 91.01M 2025-12
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Novartis USD 4.24B 171M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
United Therapeutics USD 325.8M 340.4M 2026-03
Xoma USD -15.64M 5.56M 2024-09